Role of Bone Morphogenetic Protein 2 Polymorphisms in Bone Mineral Density after the Start of Treatment with Atorvastatin

Basic and Clinical Pharmacology and Toxicology, Vol. 123, Núm. 6, 2018, pp. 766-769

  1. Usategui-Martín, R.
  2. Vega, G.
  3. Abad-Manteca, L.
  4. Ruiz-Mambrilla, M.
  5. Calero-Paniagua, I.
  6. Dueñas-Laita, A.
  7. Pérez-Castrillón, J.L.
Procedencia: